{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:09:34Z","timestamp":1790111374235,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22183MFDS366"],"award-info":[{"award-number":["22183MFDS366"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["2022\\u20132025"],"award-info":[{"award-number":["2022\\u20132025"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejpb.2026.115147","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:31:43Z","timestamp":1781022703000},"page":"115147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Site-specific enrichment of highly sialylated N-glycans in an erythropoietin\u2013hybrid Fc fusion protein"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3762-7448","authenticated-orcid":false,"given":"Juhee","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeun","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulmin","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seojeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungmi","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngho","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115147_b0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0301-472X(03)00006-7","article-title":"Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin","volume":"31","author":"Egrie","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ejpb.2026.115147_b0010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","article-title":"Regulation of erythropoietin production","volume":"589","author":"Jelkmann","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejpb.2026.115147_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.01110","article-title":"Clinical indications of recombinant human erythropoietin in a single center: a 10-year retrospective study","volume":"11","author":"Guan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115147_b0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1034\/j.1600-0609.2002.02813.x","article-title":"The enigma of the metabolic fate of circulating erythropoietin (EPO) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP","volume":"69","author":"Jelkmann","year":"2002","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejpb.2026.115147_b0025","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jnc.15475","article-title":"Erythropoietin and derivatives: potential beneficial effects on the brain","volume":"158","author":"Vittori","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejpb.2026.115147_b0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41570-020-0174-3","article-title":"Glycomics studies using sialic acid derivatization and mass spectrometry","volume":"4","author":"de Haan","year":"2020","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0035","author":"Ghosh","year":"2020","journal-title":"Sialic acid and biology of life: An introduction"},{"key":"10.1016\/j.ejpb.2026.115147_b0040","first-page":"1","article-title":"An engineered pathway for production of terminally sialylated N-glycoproteins in the periplasm of Escherichia coli, Front. Bioeng","volume":"8","author":"Zhu","year":"2020","journal-title":"Biotechnol"},{"key":"10.1016\/j.ejpb.2026.115147_b0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejpb.2026.115147_b0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-015-0133-6","article-title":"Fusion proteins for half-life extension of biologics as a strategy to make biobetters","volume":"29","author":"Strohl","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejpb.2026.115147_b0055","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/emmm.201201379","article-title":"Fc-fusion proteins: new developments and future perspectives","volume":"4","author":"Czajkowsky","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejpb.2026.115147_b0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12272-012-0500-5","article-title":"A long-acting erythropoietin fused with noncytolytic human Fc for the treatment of anemia","volume":"35","author":"Yang","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115147_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024574","article-title":"Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin","volume":"6","author":"Im","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.115147_b0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","article-title":"The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy","volume":"91","author":"Sockolosky","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115147_b0075","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500678","article-title":"Chemical synthesis of erythropoietin glycoforms for insights into the relationship between glycosylation pattern and bioactivity","volume":"2","author":"Murakami","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejpb.2026.115147_b0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/BTT.S45971","article-title":"Erythropoiesis stimulating agents: approaches to modulate activity","volume":"7","author":"Sinclair","year":"2013","journal-title":"Biol. Targets Ther."},{"key":"10.1016\/j.ejpb.2026.115147_b0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/mp100353a","article-title":"Erythropoietin produced in a human cell line (Dynepo) has significant differences in glycosylation compared with erythropoietins produced in CHO cell lines","volume":"8","author":"Shahrokh","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115147_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113031","article-title":"Glycan analysis of erythropoiesis-stimulating agents","volume":"180","author":"Cowper","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2026.115147_b0095","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1002\/elps.201100378","article-title":"Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification","volume":"32","author":"Desantos-Garcia","year":"2011","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejpb.2026.115147_b0100","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1039\/C7AN01262D","article-title":"Direct comparison of derivatization strategies for LC-MS\/MS analysis of: N-glycans","volume":"142","author":"Zhou","year":"2017","journal-title":"Analyst"},{"key":"10.1016\/j.ejpb.2026.115147_b0105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fchem.2018.00324","article-title":"Comparison of 2-aminobenzamide, procainamide and RapiFluor-MS as derivatizing agents for high-throughput HILIC-UPLC-FLR-MS N-glycan analysis","volume":"6","author":"Keser","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ab.2015.06.006","article-title":"Comparison of procainamide and 2-aminobenzamide labeling for profiling and identification of glycans liquid chromatography with fluorescence detection coupled to electrospray ionization-mass spectrometry","volume":"486","author":"Kozak","year":"2015","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2026.115147_b0115","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00216-010-3988-x","article-title":"HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals","volume":"398","author":"Melmer","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0120","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1021\/cr3003714","article-title":"High-sensitivity analytical approaches for the structural characterization of glycoproteins","volume":"113","author":"Alley","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2026.115147_b0125","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1021\/acs.analchem.5c01830","article-title":"Comprehensive glycan mapping of intact human erythropoietin by reversed-phase liquid chromatography\u2013mass spectrometry","volume":"97","author":"Baba","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0130","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1073\/pnas.69.12.3506","article-title":"Staphylococcal protease: a proteolytic enzyme specific for glutamoyl bonds","volume":"69","author":"Houmard","year":"1972","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejpb.2026.115147_b0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/C8RA07200K","article-title":"Middle-down approach: a choice to sequence and characterize proteins\/proteomes by mass spectrometry","volume":"9","author":"Pandeswari","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2026.115147_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13973-x","article-title":"Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC\u2013MS\/MS","volume":"11","author":"Bian","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2026.115147_b0145","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2026.115147_b0150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1023\/A:1006983125913","article-title":"A general approach to desalting oligosaccharides released from glycoproteins","volume":"15","author":"Packer","year":"1998","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ejpb.2026.115147_b0155","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1021\/ac5040743","article-title":"Assignment of core versus antenna fucosylation types in protein N-glycosylation via procainamide labeling and tandem mass spectrometry","volume":"87","author":"Nwosu","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0160","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1021\/ac800630x","article-title":"Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins","volume":"80","author":"Ruhaak","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129575","article-title":"Comparison of sialylated and fucosylated N-glycans attached to Asn 6 and Asn 41 with different roles in hyaluronan and proteoglycan link protein 1 (HAPLN1)","volume":"260","author":"Park","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115147_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116682","article-title":"Peptide mapping analysis of synthetic semaglutide and liraglutide for generic development of drugs originating from recombinant DNA technology","volume":"256","author":"Kim","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2026.115147_b0175","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41592-021-01306-0","article-title":"Precise, fast and comprehensive analysis of intact glycopeptides and modified glycans with pGlyco3","volume":"18","author":"Zeng","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejpb.2026.115147_b0180","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1002\/pmic.200900096","article-title":"Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds","volume":"9","author":"Harvey","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.ejpb.2026.115147_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110069","article-title":"Fucosylation and galactosylation in N-glycans of bovine intestinal alkaline phosphatase and their role in its enzymatic activity","volume":"758","author":"Jang","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejpb.2026.115147_b0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpha.2023.01.001","article-title":"Fragmentation stability and retention time-shift obtained by LC-MS\/MS to distinguish sialylated N-glycan linkage isomers in therapeutic glycoproteins","volume":"13","author":"Park","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ejpb.2026.115147_b0195","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.sbi.2009.05.005","article-title":"Mass spectrometry in the analysis of N-linked and O-linked glycans","volume":"19","author":"North","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejpb.2026.115147_b0200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/acs.analchem.7b04202","article-title":"Recent advances in the mass spectrometry methods for glycomics and cancer","volume":"90","author":"Kailemia","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0205","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1021\/pr500898r","article-title":"Assignment of saccharide identities through analysis of oxonium ion fragmentation profiles in LC-MS\/MS of glycopeptides","volume":"13","author":"Halim","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejpb.2026.115147_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2024.100211","article-title":"Roles of core fucosylation modification in immune system and diseases","volume":"4","author":"Pan","year":"2025","journal-title":"Cell Insight"},{"key":"10.1016\/j.ejpb.2026.115147_b0215","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrd2804","article-title":"Glycosylation as a strategy to improve antibody-based therapeutics","volume":"8","author":"Jefferis","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2026.115147_b0220","unstructured":"A. Varki, R.D. Cummings, J.D. Esko, P. Stanley, G.W. Hart, M. Aebi, D. Mohnen, T. Kinoshita, N.H. Packer, J.H. Prestegard, R.L. Schnaar, P.H. Seeberger, Essentials of Glycobiology, fourth ed., Cold Spring Harbor Laboratory Press, New York, 2022. https:\/\/doi. org\/10.1101\/9781621824213."},{"key":"10.1016\/j.ejpb.2026.115147_b0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-4419-7877-6_28","article-title":"O-acetylated sialic acids and their role in immune defense","volume":"705","author":"Schauer","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejpb.2026.115147_b0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejpb.2026.115147_b0235","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/bkcs.11856","article-title":"Comprehensive characterization of N-glycosylation in darbepoetin alfa","volume":"40","author":"Lee","year":"2019","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejpb.2026.115147_b0240","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.011015","article-title":"Mass spectrometry-based proteomics using Q exactive, a high-performance benchtop quadrupole orbitrap mass spectrometer","volume":"10","author":"Michalski","year":"2011","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.ejpb.2026.115147_b0245","doi-asserted-by":"crossref","first-page":"11691","DOI":"10.1021\/acs.analchem.5b02366","article-title":"Site-specific protein N- and O-glycosylation analysis by a C18-porous graphitized carbon-liquid chromatography-electrospray ionization mass spectrometry approach using pronase treated glycopeptides","volume":"87","author":"Stavenhagen","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0250","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1021\/acs.analchem.5c02433","article-title":"Unveiling the accurate site-specific N- and O-glycosylation of hyperglycosylated erythropoietin drugs by an integrated approach","volume":"97","author":"Wu","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.115147_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.enzmictec.2019.109482","article-title":"Profiles of plant core-fucosylated N-glycans of acid alpha-glucosidases produced in transgenic rice cell suspension cultures treated with eight different conditions","volume":"134","author":"Kim","year":"2020","journal-title":"Enzyme Microb. Technol."},{"key":"10.1016\/j.ejpb.2026.115147_b0260","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1021\/acs.jproteome.0c00218","article-title":"Optimal dissociation methods differ for N- and O-glycopeptides","volume":"19","author":"Riley","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejpb.2026.115147_b0265","first-page":"1655","article-title":"Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies","volume":"2016","author":"Le","year":"1860","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.ejpb.2026.115147_b0270","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.drudis.2007.02.010","article-title":"Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells","volume":"12","author":"Byrne","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2026.115147_b0275","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpba.2018.02.043","article-title":"Comprehensive glycan analysis of twelve recombinant human erythropoietin preparations from manufacturers in China and Japan","volume":"153","author":"Cowper","year":"2018","journal-title":"J. Pharm. Biomed. Anal."}],"updated-by":[{"DOI":"10.1016\/j.ejpb.2026.115157","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000}},{"DOI":"10.1016\/j.ejpb.2026.115157","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:44:35Z","timestamp":1790109875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"alternative-id":["S0939641126001682"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115147","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-specific enrichment of highly sialylated N-glycans in an erythropoietin\u2013hybrid Fc fusion protein","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115147"}}